{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:28:54Z","timestamp":1793795334965,"version":"4.6.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate whether the choice of antipsychotic treatment following traumatic brain injury (TBI) hospitalization is associated with the risk of post-traumatic epilepsy in older adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN:<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING:<\/jats:title>\n                    <jats:p>Population-based cohort in Ontario, Canada (2009\u20132021).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS:<\/jats:title>\n                    <jats:p>We included adults 66 years or older without epilepsy who survived a first TBI admission and filled new prescriptions for antipsychotics within 30 days after discharge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n                    <jats:p>The exposure groups included patients who were prescribed haloperidol or risperidone, compared separately to quetiapine. The primary outcome was a new diagnosis of epilepsy up to 5 years following discharge. We used inverse probability of treatment weighting of cause-specific Cox models to calculate adjusted hazard ratios (aHR) and 95% CIs based on a robust variance estimator. Of 1204 TBI survivors included, 202 (17%) filled prescriptions for haloperidol, 300 (25%) for risperidone, and 702 (58%) for quetiapine; epilepsy was diagnosed in 6%, 13%, and 14% of these groups, respectively. Mortality by 5 years of follow-up was 89% for haloperidol, 66% for risperidone, and 62% for quetiapine. Compared with quetiapine, a new prescription for haloperidol (aHR = 0.73; 95% CI, 0.39\u20131.34) or risperidone (aHR = 0.94; 95% CI, 0.65\u20131.36) was not associated with higher epilepsy risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>We found no clear signal of a differential risk of epilepsy when comparing new prescriptions for haloperidol or risperidone with quetiapine among survivors of TBI. Nonetheless, high mortality limited comparability across groups, CIs were wide, and additional studies should confirm our findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000007335","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:06:51Z","timestamp":1789999611000},"page":"2880-2890","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Epilepsy After Antipsychotic Prescription in Survivors of Traumatic Brain Injury: A Population-Based Cohort Study"],"prefix":"10.1097","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4538-4197","authenticated-orcid":false,"given":"Augusto","family":"Ferraris","sequence":"first","affiliation":[{"name":"Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro G.","family":"Szmulewicz","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, T.H. Chan School of Public Health, Harvard University, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neill K. J.","family":"Adhikari","sequence":"additional","affiliation":[{"name":"Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada."},{"name":"Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada."},{"name":"Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Burry","sequence":"additional","affiliation":[{"name":"Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada."},{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada."},{"name":"Department of Pharmacy, Sinai Health, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"ICES, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Wunsch","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Weill Cornell Medicine, New York City, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon C.","family":"Scales","sequence":"additional","affiliation":[{"name":"Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada."},{"name":"Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada."},{"name":"Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Angriman","sequence":"additional","affiliation":[{"name":"Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada."},{"name":"Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada."},{"name":"Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"R2-20261104","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2318-13-97","article-title":"Older adults with acquired brain injury: A population based study.","volume":"13","author":"Chan","year":"2013","journal-title":"BMC Geriatr"},{"key":"R3-20261104","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.biopsych.2021.09.024","article-title":"Mental health consequences of traumatic brain injury.","volume":"91","author":"Howlett","year":"2022","journal-title":"Biol Psychiatry"},{"key":"R4-20261104","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s00415-020-09926-w","article-title":"A review of seizures and epilepsy following traumatic brain injury.","volume":"267","author":"Fordington","year":"2020","journal-title":"J Neurol"},{"key":"R5-20261104","doi-asserted-by":"crossref","first-page":"e2450499","DOI":"10.1001\/jamanetworkopen.2024.50499","article-title":"Traumatic brain injury and risk of incident comorbidities.","volume":"7","author":"Halabi","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R6-20261104","first-page":"e1160","article-title":"Antiseizure medications in adult patients with traumatic brain injury: A systematic review and Bayesian network meta-analysis.","volume":"6","author":"Angriman","year":"2024","journal-title":"Crit Care Explor"},{"key":"R7-20261104","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/HTR.0000000000000614","article-title":"The use of atypical antipsychotics for managing agitation after traumatic brain injury.","volume":"36","author":"McKay","year":"2021","journal-title":"J Head Trauma Rehabil"},{"key":"R8-20261104","doi-asserted-by":"crossref","first-page":"e029604","DOI":"10.1136\/bmjopen-2019-029604","article-title":"Pharmacological interventions for agitated behaviours in patients with traumatic brain injury: A systematic review.","volume":"9","author":"Williamson","year":"2019","journal-title":"BMJ Open"},{"key":"R9-20261104","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5603\/PJNNS.a2019.0052","article-title":"Antipsychotic drugs in epilepsy.","volume":"53","author":"G\u00f3rska","year":"2019","journal-title":"Neurol Neurochir Pol"},{"key":"R11-20261104","doi-asserted-by":"crossref","first-page":"e0287929","DOI":"10.1371\/journal.pone.0287929","article-title":"Impacts of antipsychotic medication prescribing practices in critically ill adult patients on health resource utilization and new psychoactive medication prescriptions.","volume":"18","author":"Jaworska","year":"2023","journal-title":"PLoS One"},{"key":"R12-20261104","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.curtheres.2018.08.002","article-title":"Antipsychotic drug dispensations in older adults, including continuation after a fall-related hospitalization: Identifying adherence to screening tool of older persons\u2019 potentially inappropriate prescriptions criteria using the Nova Scotia Seniors\u2019 Pharmacare Program and Canadian Institute for Health\u2019s Discharge Databases.","volume":"89","author":"Trenaman","year":"2018","journal-title":"Curr Ther Res Clin Exp"},{"key":"R13-20261104","doi-asserted-by":"crossref","first-page":"e010861","DOI":"10.1136\/bmjopen-2015-010861","article-title":"Quetiapine use in adults in the community: A population-based study in Alberta, Canada.","volume":"6","author":"Duncan","year":"2016","journal-title":"BMJ Open"},{"key":"R14-20261104","doi-asserted-by":"crossref","first-page":"e5747","DOI":"10.1002\/pds.5747","article-title":"New antipsychotic prescription and recurrent infections among adult sepsis survivors: A population\u2010based cohort study.","volume":"33","author":"Ferraris","year":"2024","journal-title":"Pharmacoepidemiol Drug"},{"key":"R15-20261104","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"Ethical principles for medical research involving human subjects.","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"R16-20261104","doi-asserted-by":"crossref","first-page":"k3532","DOI":"10.1136\/bmj.k3532","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE).","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"key":"R17-20261104","doi-asserted-by":"crossref","first-page":"106213","DOI":"10.1016\/j.ypmed.2020.106213","article-title":"Pre-injury health status and excess mortality in persons with traumatic brain injury: A decade-long historical cohort study.","volume":"139","author":"Mollayeva","year":"2020","journal-title":"Prev Med"},{"key":"R18-20261104","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pds.5547","article-title":"Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies.","volume":"32","author":"Acton","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R19-20261104","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S2215-0366(24)00314-6","article-title":"Prevalence, correlates, tolerability-related outcomes, and efficacy-related outcomes of antipsychotic polypharmacy: A systematic review and meta-analysis.","volume":"11","author":"H\u00f8jlund","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"R20-20261104","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1528-1167.2009.02201.x","article-title":"How accurate is ICD coding for epilepsy?","volume":"51","author":"Jett\u00e9","year":"2010","journal-title":"Epilepsia"},{"key":"R21-20261104","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/jamainternmed.2019.0086","article-title":"A clinical overview of off-label use of gabapentinoid drugs.","volume":"179","author":"Goodman","year":"2019","journal-title":"JAMA Intern Med"},{"key":"R22-20261104","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11606-023-08418-7","article-title":"Gabapentinoid use by self-reported indication and level of evidence.","volume":"39","author":"Chaitoff","year":"2024","journal-title":"J Gen Intern Med"},{"key":"R23-20261104","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrrheum.2015.30","article-title":"Active-comparator design and new-user design in observational studies.","volume":"11","author":"Yoshida","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"R24-20261104","doi-asserted-by":"crossref","first-page":"3000605241241920","DOI":"10.1177\/03000605241241920","article-title":"Making causal inferences from transactional data: A narrative review of opportunities and challenges when implementing the target trial framework.","volume":"52","author":"Esteban","year":"2024","journal-title":"J Int Med Res"},{"key":"R25-20261104","doi-asserted-by":"crossref","first-page":"335","DOI":"10.9740\/mhc.2020.11.335","article-title":"Traumatic brain injury and mood disorders.","volume":"10","author":"Robert","year":"2020","journal-title":"Ment Health Clin"},{"key":"R26-20261104","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00134-022-06634-z","article-title":"Sepsis hospitalization and risk of subsequent cardiovascular events in adults: A population-based matched cohort study.","volume":"48","author":"Angriman","year":"2022","journal-title":"Intensive Care Med"},{"key":"R27-20261104","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R28-20261104","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.chest.2022.12.033","article-title":"New and persistent sedative prescriptions among older adults following a critical illness.","volume":"163","author":"Burry","year":"2023","journal-title":"Chest"},{"key":"R29-20261104","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"R30-20261104","doi-asserted-by":"crossref","first-page":"e905","DOI":"10.4088\/JCP.16m10976","article-title":"Long-term antipsychotic use and major cardiovascular events: A retrospective cohort study.","volume":"78","author":"Szmulewicz","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"R31-20261104","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/TA.0000000000004052","article-title":"Internal and external validation of an updated ICD-10-CA to AIS-2005 update 2008 algorithm.","volume":"96","author":"Tillmann","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"key":"R32-20261104","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection.","volume":"34","author":"VanderWeele","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"R33-20261104","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.ede.0000135174.63482.43","article-title":"A structural approach to selection bias.","volume":"15","author":"Hern\u00e1n","year":"2004","journal-title":"Epidemiology"},{"key":"R34-20261104","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1164\/rccm.202305-0790CP","article-title":"Accounting for competing events when evaluating long-term outcomes in survivors of critical illness.","volume":"208","author":"Angriman","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"R35-20261104","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data.","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R36-20261104","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/2040622316658463","article-title":"Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses.","volume":"7","author":"Tampi","year":"2016","journal-title":"Ther Adv Chronic Dis"},{"key":"R37-20261104","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40266-021-00837-7","article-title":"Seizures and epilepsy after stroke: Epidemiology, biomarkers and management.","volume":"38","author":"Galovic","year":"2021","journal-title":"Drugs Aging"},{"key":"R38-20261104","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ana.26443","article-title":"Risk factors and incidence of epilepsy after severe traumatic brain injury.","volume":"92","author":"Pease","year":"2022","journal-title":"Ann Neurol"},{"key":"R39-20261104","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM199801013380104","article-title":"A population-based study of seizures after traumatic brain injuries.","volume":"338","author":"Annegers","year":"1998","journal-title":"N Engl J Med"},{"key":"R40-20261104","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jamaneurol.2021.5420","article-title":"Risk factors and prognosis of early posttraumatic seizures in moderate to severe traumatic brain injury.","volume":"79","author":"Laing","year":"2022","journal-title":"JAMA Neurol"},{"key":"R41-20261104","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(09)60214-2","article-title":"Long-term risk of epilepsy after traumatic brain injury in children and young adults: A population-based cohort study.","volume":"373","author":"Christensen","year":"2009","journal-title":"Lancet (London)"},{"key":"R42-20261104","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/epi.18248","article-title":"Mediators of epilepsy risk after traumatic brain injury: A 20\u2010year U.S. veteran cohort study.","volume":"66","author":"Vadlamani","year":"2025","journal-title":"Epilepsia"},{"key":"R43-20261104","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11910-016-0670-5","article-title":"The impact of psychoactive drugs on seizures and antiepileptic drugs.","volume":"16","author":"Habibi","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R44-20261104","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1097\/HTR.0b013e31827340ba","article-title":"Mortality after surviving traumatic brain injury: Risks based on age groups.","volume":"27","author":"Harrison-Felix","year":"2012","journal-title":"J Head Trauma Rehabil"},{"key":"R45-20261104","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.apmr.2009.08.151","article-title":"Mortality after discharge from acute care hospitalization with traumatic brain injury: A population-based study.","volume":"91","author":"Ventura","year":"2010","journal-title":"Arch Phys Med Rehabil"},{"key":"R46-20261104","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/aje\/kwad090","article-title":"Considering questions before methods in dementia research with competing events and causal goals.","volume":"192","author":"Rojas-Saunero","year":"2023","journal-title":"Am J Epidemiol"},{"key":"R47-20261104","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks.","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"R48-20261104","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.18632\/oncotarget.23729","article-title":"Competing risks and cancer-specific mortality: Why it matters.","volume":"9","author":"Tan","year":"2018","journal-title":"Oncotarget"},{"key":"R49-20261104","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/JMDH.S104807","article-title":"Information bias in health research: Definition, pitfalls, and adjustment methods.","volume":"9","author":"Althubaiti","year":"2016","journal-title":"J Multidiscip Healthc"},{"key":"R50-20261104","first-page":"jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults.","volume":"71","year":"2023","journal-title":"J Am Geriatr Soc"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:00:44Z","timestamp":1793793644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000007335","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}